BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31779577)

  • 1. A meta-analysis approach for estimating average unit costs for ART using pooled facility-level primary data from African countries.
    Cerecero-García D; Pineda-Antunez C; Alexander L; Cameron D; Martinez-Silva G; Obure CD; Marseille E; Vu L; Kahn JG; Vassall A; Gomez G; Bollinger L; Levin C; Bautista-Arredondo S
    Afr J AIDS Res; 2019 Dec; 18(4):297-305. PubMed ID: 31779577
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of average costs of HIV testing and counselling and voluntary medical male circumcision across thirteen countries.
    Pineda-Antunez C; Martinez-Silva G; Cerecero-Garcia D; Alexander L; Cameron DB; Chiwevu C; Dandona L; Obure CD; Forsythe S; Nguyen VT; Settumba S; Tchuenche M; Van Minh H; Kahn JG; Gomez G; Sweeney S; Vassall A; Bollinger L; Levin C; Bautista-Arredondo S
    Afr J AIDS Res; 2019 Dec; 18(4):341-349. PubMed ID: 31779565
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
    Barker C; Dutta A; Klein K
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventions.
    Bautista-Arredondo S; La Hera-Fuentes G; Contreras-Loya D; Kwan A; Van Buren SJ; Amanze OO; Atobatele A; Adeyemi A; Abatta E; Ogungbemi KM; Sosa-Rubí SG
    PLoS One; 2018; 13(9):e0201706. PubMed ID: 30192765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia.
    Bautista-Arredondo S; Sosa-Rubi SG; Opuni M; Contreras-Loya D; La Hera-Fuentes G; Kwan A; Chaumont C; Chompolola A; Condo J; Dzekedzeke K; Galarraga O; Martinson N; Masiye F; Nsanzimana S; Wamai R; Wang'ombe J;
    PLoS One; 2018; 13(9):e0203121. PubMed ID: 30212497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics.
    Bautista-Arredondo S; Colchero MA; Amanze OO; La Hera-Fuentes G; Silverman-Retana O; Contreras-Loya D; Ashefor GA; Ogungbemi KM
    PLoS One; 2018; 13(5):e0194305. PubMed ID: 29718906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.
    Larson BA; Bii M; Henly-Thomas S; McCoy K; Sawe F; Shaffer D; Rosen S
    J Int AIDS Soc; 2013 Jan; 16(1):18026. PubMed ID: 23305696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?
    Aliyu HB; Chuku NN; Kola-Jebutu A; Abubakar Z; Torpey K; Chabikuli ON
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):221-5. PubMed ID: 22820805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
    Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
    Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and outcomes of paediatric antiretroviral treatment in South Africa.
    Meyer-Rath G; Brennan A; Long L; Ndibongo B; Technau K; Moultrie H; Fairlie L; Coovadia A; Rosen S
    AIDS; 2013 Jan; 27(2):243-50. PubMed ID: 23014517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future "test and start" strategies.
    Vyas S; Songo J; Guinness L; Dube A; Geis S; Kalua T; Todd J; Renju J; Crampin A; Wringe A
    BMC Health Serv Res; 2020 Aug; 20(1):740. PubMed ID: 32787835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
    Gutierrez JP; Johns B; Adam T; Bertozzi SM; Edejer TT; Greener R; Hankins C; Evans DB
    Lancet; 2004 Jul 3-9; 364(9428):63-4. PubMed ID: 15234857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of staff and workload profiles in retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa.
    Vella V; Govender T; Dlamini SS; Moodley I; David V; Taylor M; Jinabhai CC
    AIDS Care; 2011 Sep; 23(9):1146-53. PubMed ID: 21562993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of antiretroviral treatment services in India: Estimated costs incurred under the National AIDS Control Programme.
    Agarwal R; Rewari BB; Shastri S; Nagaraja SB; Rathore AS
    WHO South East Asia J Public Health; 2017 Apr; 6(1):94-98. PubMed ID: 28597866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving away from the "unit cost". Predicting country-specific average cost curves of VMMC services accounting for variations in service delivery platforms in sub-Saharan Africa.
    Bautista-Arredondo S; Pineda-Antunez C; Cerecero-Garcia D; Cameron DB; Alexander L; Chiwevu C; Forsythe S; Tchuenche M; Dow WH; Kahn J; Gomez GB; Vassall A; Bollinger LA; Levin C
    PLoS One; 2021; 16(4):e0249076. PubMed ID: 33886576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.
    Obure CD; Sweeney S; Darsamo V; Michaels-Igbokwe C; Guinness L; Terris-Prestholt F; Muketo E; Nhlabatsi Z; ; Warren CE; Mayhew S; Watts C; Vassall A
    PLoS One; 2015; 10(5):e0124476. PubMed ID: 25933414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.